Accuray Inc (ARAY)

$1.22 -0.01 (-0.81%)
Market Cap 125.68M
Revenue (ttm) 446.55M
Net Income (ttm) -15.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 123.00
Profit Margin -3.48%
Debt to Equity Ratio 3.35
Volume 610,700
Avg Vol 855,432
Day's Range N/A - N/A
Shares Out 103.01M
Stochastic %K 8%
Beta 1.30
Analysts Strong Sell
Price Target $5.38

Company Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine a...

Industry: Medical Devices
Sector: Healthcare
Phone: 608 824 2800
Fax: 608 824 2996
Address:
1240 Deming Way, Madison, United States
ZacksResearch
ZacksResearch Jun. 18 at 4:32 PM
$ARAY poised for growth despite market challenges! 📈 🔹 Strong Q3 results: 12% YoY total net revenue growth, driven by 23% unit sales jump and robust demand in developed & emerging markets. 🔹 CyberKnife System shines with more than 50% revenue growth in Q2, especially in China & Japan. But beware: Tariffs could impact Q4 shipments to China, risking $10–$15 million in revenue. ⚠️ Discover ARAY's full potential and risks here 👉 https://www.zacks.com/commentary/2510745/heres-why-you-should-hold-accuray-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2510745-body&ADID=SYND_STOCKTWITS_TWEET_2_2510745_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 18 at 2:18 PM
$ARAY showing strength where it matters — is it time to hold? The CyberKnife system remains a key growth driver, and global performance is holding up well. Full breakdown here 👉 https://www.zacks.com/stock/news/2510745/heres-why-you-should-hold-accuray-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2510745-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2510745_TEASER
0 · Reply
MSUalum
MSUalum Jun. 17 at 8:13 PM
$ARAY Insider Joseph E Whitters purchased a total of 50,000 shares at a price of 1.25 in an open market transaction 6/13. Bottom line, it is a start, but not enough. Need to see more insiders buying.
0 · Reply
bilocelhi
bilocelhi Jun. 16 at 11:24 PM
$ARAY has no chance against $PTHL
0 · Reply
PenkeTrading
PenkeTrading Jun. 14 at 12:18 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Accuray Incorporated. Is that bullish or bearish? $ARAY #Accuray #RsiOversold #NASDAQ
0 · Reply
dbcoop1
dbcoop1 Jun. 9 at 7:17 PM
$ARAY GLTA i am out I have no confidense in this POS
1 · Reply
goldenmanchurian
goldenmanchurian Jun. 9 at 2:58 AM
$ARAY never made profit, company has been used as ATM for management to cash out on investors in the past 15 years
0 · Reply
Georges8792
Georges8792 Jun. 8 at 5:56 AM
$ARAY max 190 million new debt at roughly 10% interest rate? Wow … plus still some dilution with the warrants. I hope they have good plans for the next years
0 · Reply
UgoGreg
UgoGreg Jun. 6 at 8:55 PM
$ARAY https://youtu.be/FJhruzV5eBQ
0 · Reply
dbcoop1
dbcoop1 Jun. 6 at 6:42 PM
$ARAY This is one Train I regret getting on
1 · Reply
Latest News on ARAY
Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Jun 6, 2025, 7:30 AM EDT - 15 days ago

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

May 29, 2025, 7:30 PM EDT - 23 days ago

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

May 7, 2025, 7:35 AM EDT - 6 weeks ago

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System

May 5, 2025, 4:10 PM EDT - 6 weeks ago

Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System

Accuray: Tariffs Are The Latest Obstacle For A Company That Has Struggled To Deliver (Rating Downgrade)

May 3, 2025, 2:52 AM EDT - 7 weeks ago

Accuray: Tariffs Are The Latest Obstacle For A Company That Has Struggled To Deliver (Rating Downgrade)

Accuray Incorporated (ARAY) Q3 2025 Earnings Call Transcript

Apr 30, 2025, 10:38 PM EDT - 7 weeks ago

Accuray Incorporated (ARAY) Q3 2025 Earnings Call Transcript

Accuray Reports Fiscal 2025 Third Quarter Financial Results

Apr 30, 2025, 4:05 PM EDT - 7 weeks ago

Accuray Reports Fiscal 2025 Third Quarter Financial Results

Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting

Apr 3, 2025, 7:35 AM EDT - 2 months ago

Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting

Accuray to Participate at 37th Annual Roth Conference

Mar 12, 2025, 7:30 AM EDT - 3 months ago

Accuray to Participate at 37th Annual Roth Conference

Accuray Incorporated (ARAY) Q2 2025 Earnings Call Transcript

Feb 5, 2025, 10:03 PM EST - 4 months ago

Accuray Incorporated (ARAY) Q2 2025 Earnings Call Transcript

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Feb 5, 2025, 4:05 PM EST - 4 months ago

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Jan 23, 2025, 7:35 AM EST - 5 months ago

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Jan 22, 2025, 4:05 PM EST - 5 months ago

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Leonel Peralta to Join Accuray as Chief Operations Officer

Jan 21, 2025, 9:15 AM EST - 5 months ago

Leonel Peralta to Join Accuray as Chief Operations Officer

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System

Jan 13, 2025, 3:00 PM EST - 5 months ago

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System

Accuray - There's Value If Linac Sales Accelerate, But That's A Big 'If'

Jan 7, 2025, 10:52 AM EST - 5 months ago

Accuray - There's Value If Linac Sales Accelerate, But That's A Big 'If'

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat

Dec 18, 2024, 7:35 AM EST - 6 months ago

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Nov 26, 2024, 4:03 PM EST - 7 months ago

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript

Nov 6, 2024, 10:29 PM EST - 8 months ago

Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript

Accuray Reports Fiscal 2025 First Quarter Financial Results

Nov 6, 2024, 4:05 PM EST - 8 months ago

Accuray Reports Fiscal 2025 First Quarter Financial Results

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024

Oct 23, 2024, 4:05 PM EDT - 8 months ago

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024

Accuray Appoints Michael Murphy as VP, Corporate Controller

Oct 21, 2024, 4:05 PM EDT - 8 months ago

Accuray Appoints Michael Murphy as VP, Corporate Controller

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

Oct 15, 2024, 8:45 AM EDT - 8 months ago

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training

Sep 30, 2024, 7:35 AM EDT - 9 months ago

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training

Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution

Sep 10, 2024, 5:30 PM EDT - 10 months ago

Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence

Sep 3, 2024, 4:10 PM EDT - 10 months ago

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence

Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™

Aug 27, 2024, 7:35 AM EDT - 10 months ago

Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™

Accuray Remains A Perpetual 'Next Year Is Our Year' Story

Aug 18, 2024, 11:55 AM EDT - 10 months ago

Accuray Remains A Perpetual 'Next Year Is Our Year' Story

Accuray Incorporated (ARAY) Q4 2024 Earnings Call Transcript

Aug 14, 2024, 9:02 PM EDT - 11 months ago

Accuray Incorporated (ARAY) Q4 2024 Earnings Call Transcript

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results

Aug 14, 2024, 4:05 PM EDT - 11 months ago

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results

Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology

Aug 13, 2024, 7:35 AM EDT - 11 months ago

Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology

Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024

Jul 31, 2024, 4:05 PM EDT - 11 months ago

Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024

Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care

Jun 27, 2024, 7:35 AM EDT - 1 year ago

Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care

Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients

Jun 20, 2024, 7:35 AM EDT - 1 year ago

Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients

Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration

Jun 12, 2024, 7:35 AM EDT - 1 year ago

Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration

Accuray to Participate in the Jefferies Global Healthcare Conference 2024

May 22, 2024, 4:30 PM EDT - 1 year ago

Accuray to Participate in the Jefferies Global Healthcare Conference 2024

Accuray Incorporated (ARAY) Q3 2024 Earnings Call Transcript

May 1, 2024, 9:36 PM EDT - 1 year ago

Accuray Incorporated (ARAY) Q3 2024 Earnings Call Transcript

Accuray Reports Fiscal 2024 Third Quarter Financial Results

May 1, 2024, 4:06 PM EDT - 1 year ago

Accuray Reports Fiscal 2024 Third Quarter Financial Results

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

Apr 25, 2024, 7:35 AM EDT - 1 year ago

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

Apr 18, 2024, 7:35 AM EDT - 1 year ago

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024

Apr 17, 2024, 4:05 PM EDT - 1 year ago

Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024

Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp

Apr 7, 2024, 12:25 AM EDT - 1 year ago

Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Mar 26, 2024, 7:35 AM EDT - 1 year ago

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Accuray Incorporated to Speak at 36th Annual Roth Conference

Mar 4, 2024, 4:30 PM EST - 1 year ago

Accuray Incorporated to Speak at 36th Annual Roth Conference

Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Feb 27, 2024, 5:30 PM EST - 1 year ago

Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System

Feb 13, 2024, 7:35 AM EST - 1 year ago

Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System

Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Feb 5, 2024, 5:30 PM EST - 1 year ago

Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript

Jan 31, 2024, 10:03 PM EST - 1 year ago

Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript

Accuray Reports Fiscal 2024 Second Quarter Financial Results

Jan 31, 2024, 4:06 PM EST - 1 year ago

Accuray Reports Fiscal 2024 Second Quarter Financial Results

Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions

Jan 25, 2024, 7:35 AM EST - 1 year ago

Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions

ZacksResearch
ZacksResearch Jun. 18 at 4:32 PM
$ARAY poised for growth despite market challenges! 📈 🔹 Strong Q3 results: 12% YoY total net revenue growth, driven by 23% unit sales jump and robust demand in developed & emerging markets. 🔹 CyberKnife System shines with more than 50% revenue growth in Q2, especially in China & Japan. But beware: Tariffs could impact Q4 shipments to China, risking $10–$15 million in revenue. ⚠️ Discover ARAY's full potential and risks here 👉 https://www.zacks.com/commentary/2510745/heres-why-you-should-hold-accuray-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2510745-body&ADID=SYND_STOCKTWITS_TWEET_2_2510745_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 18 at 2:18 PM
$ARAY showing strength where it matters — is it time to hold? The CyberKnife system remains a key growth driver, and global performance is holding up well. Full breakdown here 👉 https://www.zacks.com/stock/news/2510745/heres-why-you-should-hold-accuray-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2510745-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2510745_TEASER
0 · Reply
MSUalum
MSUalum Jun. 17 at 8:13 PM
$ARAY Insider Joseph E Whitters purchased a total of 50,000 shares at a price of 1.25 in an open market transaction 6/13. Bottom line, it is a start, but not enough. Need to see more insiders buying.
0 · Reply
bilocelhi
bilocelhi Jun. 16 at 11:24 PM
$ARAY has no chance against $PTHL
0 · Reply
PenkeTrading
PenkeTrading Jun. 14 at 12:18 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Accuray Incorporated. Is that bullish or bearish? $ARAY #Accuray #RsiOversold #NASDAQ
0 · Reply
dbcoop1
dbcoop1 Jun. 9 at 7:17 PM
$ARAY GLTA i am out I have no confidense in this POS
1 · Reply
goldenmanchurian
goldenmanchurian Jun. 9 at 2:58 AM
$ARAY never made profit, company has been used as ATM for management to cash out on investors in the past 15 years
0 · Reply
Georges8792
Georges8792 Jun. 8 at 5:56 AM
$ARAY max 190 million new debt at roughly 10% interest rate? Wow … plus still some dilution with the warrants. I hope they have good plans for the next years
0 · Reply
UgoGreg
UgoGreg Jun. 6 at 8:55 PM
$ARAY https://youtu.be/FJhruzV5eBQ
0 · Reply
dbcoop1
dbcoop1 Jun. 6 at 6:42 PM
$ARAY This is one Train I regret getting on
1 · Reply
MSUalum
MSUalum Jun. 6 at 1:43 PM
$ARAY if CEO is so "proud" of this financing then i expect her to be buying shares at this "cheap" level. Pitiful.
0 · Reply
UgoGreg
UgoGreg Jun. 6 at 1:22 PM
$ARAY https://youtu.be/FJhruzV5eBQ
0 · Reply
Profitrip
Profitrip Jun. 6 at 12:53 PM
$ARAY restructures debt, secures new $190M financing; shares down
1 · Reply
Koelschejung82
Koelschejung82 Jun. 6 at 12:07 PM
$ARAY Dilution
0 · Reply
Starlord10
Starlord10 Jun. 6 at 12:02 PM
$ARAY https://finance.yahoo.com/news/accuray-announces-convertible-notes-exchange-113000326.html
0 · Reply
biggsk
biggsk Jun. 3 at 1:19 PM
$ARAY https://www.defenseworld.net/2025/06/01/wall-street-zen-upgrades-accuray-nasdaqaray-to-buy.html
0 · Reply
dbcoop1
dbcoop1 May. 30 at 11:14 AM
$ARAY It's really hard for me to see this Company performing so poorly with all the good reports it had in the past. What is holding it down any suggestions?
0 · Reply
biggsk
biggsk May. 29 at 11:25 PM
$ARAY https://www.defenseworld.net/2025/05/27/northern-trust-corp-increases-stock-position-in-accuray-incorporated-nasdaqaray.html
0 · Reply
HypnoTrader
HypnoTrader May. 21 at 1:14 AM
$ARAY what is wrong with this thing? Over $330 million in revenues per year, but market cap only $174 million, and that is counting all convertible debt. Any idea?
0 · Reply
VinWeezel
VinWeezel May. 18 at 3:02 PM
$ARAY 2$ this week?
1 · Reply
MSUalum
MSUalum May. 14 at 2:11 PM
$ARAY latest tute filings show 5 of the 6 top holders all ADDED (and the 6th hasn't filed yet). Sure doesn't seem like anyone is throwing in the towel to me. They have years upon years of REAL WORLD data with great outcomes.
0 · Reply
BioHuntingTwits
BioHuntingTwits May. 12 at 9:48 AM
$ARAY Now that there is a deal with China this one should fly. The earnings were very good and the only reason it is not above 2s is the lower of guidance due to tariffs which are on hold.
0 · Reply